TABLE 1.
SARS-CoV-2 variant | Mean casirivimab plasma concentration ± SD (µg/mL) |
Mean imdevimab plasma concentration ± SD (µg/mL) |
||||||
---|---|---|---|---|---|---|---|---|
4 dpi | 6 dpi | 4 dpi | 6 dpi | |||||
Vehicle control | Ronapreve (400 µg) |
Vehicle control |
Ronapreve (400 µg) |
Vehicle control | Ronapreve (400 µg) |
Vehicle control | Ronapreve (400 µg) |
|
Delta (B.1.617.2) |
<LLQ | 28.09 ± 0.38 | <LLQ | 28.74 ± 5.04 | <LLQ | 43.94 ± 3.12 | <LLQ | 41.80 ± 4.88 |
Omicron (B.1.1.529/BA.1) |
<LLQ | 27.76 ± 0.72 | <LLQ | 34.40 ± 4.29 | <LLQ | 46.90 ± 3.34 | <LLQ | 40.88 ± 0.93 |
Unpaired t-test | - | P = 0.315 | - | P = 0.887 | - | P = 0.127 | - | P = 0.661 |
Mice were inoculated with 103 PFU of SARS-CoV-2 Delta or Omicron and treated with a single intraperitoneal dose of the saline vehicle control or 400 µg Ronapreve in saline. Quantitative detection of each monoclonal antibody was completed separately using ELISA. <LLQ, below the lower limit of quantification.